FLUNINE
Live / Applied — Statement of use — processing complete, to examiner (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 12 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98645616
- Mark type
- Stylized text
- Filed
- 12 Jul 2024
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Harry B. Ray
Goods and services
- Class 005 — Pharmaceuticals: Veterinary pharmaceutical formulation of a potent, non-narcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity
Owner
- Cronus Pharma LLC, East Brunswick, NJ, US
- Cronus Pharma LLC, East Brunswick, NJ, US
Prosecution history
- 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Aug 2025 — USE AMENDMENT FILED
- 11 Mar 2026 — SOU EXTENSION 2 GRANTED
- 03 Mar 2026 — SOU EXTENSION 2 FILED
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2025 — SOU EXTENSION 1 GRANTED
- 18 Aug 2025 — SOU EXTENSION 1 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION